Olopatadin
Olopatadin
Klinički podaci
Robne marke
Olopatadine Hydrochloride, Patanol
AHFS/Drugs.com
Monografija
Identifikatori
CAS broj
113806-05-6
ATC kod
S01 GX09 , R01 AC08
PubChem [1] [2]
5281071
DrugBank
DB00768
ChemSpider [3]
4444528
KEGG [4]
C07789 Y
ChEMBL [5]
CHEMBL1189432 Y
Hemijski podaci
Formula
C 21 H 23 N O 3
Mol. masa
337,412
SMILES
eMolekuli & PubHem
InChI
InChI=1S/C21H23NO3/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24)/b18-8- Key: JBIMVDZLSHOPLA-LSCVHKIXSA-N Y
Fizički podaci
Tačka topljenja
248 °C (478 °F)
Farmakokinetički podaci
Poluvreme eliminacije
3 h
Farmakoinformacioni podaci
Trudnoća
?
Pravni status
Način primene
Oftalmički
Olopatadin je organsko jedinjenje , koje sadrži 21 atom ugljenika i ima molekulsku masu od 337,412 Da .[6] [7] [8] [9] [10] [11] [12]
Osobine
Reference
↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.” . Drug Discov Today 15 (23-24): 1052-7. DOI :10.1016/j.drudis.2010.10.003 . PMID 20970519 . edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4 : 217-241. DOI :10.1016/S1574-1400(08)00012-1 .
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining” . J Cheminform 2 (1): 3. DOI :10.1186/1758-2946-2-3 . PMID 20331846 . edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG” . Yeast 17 (1): 48–55. DOI :10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H .
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI :10.1093/nar/gkr777 . PMID 21948594 . edit
↑ Ohmori K, Hayashi K, Kaise T, Ohshima E, Kobayashi S, Yamazaki T, Mukouyama A: Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug. Jpn J Pharmacol. 2002 Apr;88(4):379-97. PMID 12046981
↑ Yanni JM, Stephens DJ, Miller ST, Weimer LK, Graff G, Parnell D, Lang LS, Spellman JM, Brady MT, Gamache DA: The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent. J Ocul Pharmacol Ther. 1996 Winter;12(4):389-400. PMID 8951675
↑ Ohmori K, Hasegawa K, Tamura T, Miyake K, Matsubara M, Masaki S, Karasawa A, Urayama N, Horikoshi K, Kajita J, Hasegawa M, Taniguchi K, Komada T, Kawamoto Y: Properties of olopatadine hydrochloride, a new antiallergic/antihistaminic drug. Arzneimittelforschung. 2004;54(12):809-29. PMID 15646365
↑ Ohmori K, Ikemura T, Kobayashi H, Mukouyama A: [Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride' (olopatadine), an antiallergic drug] Nippon Yakurigaku Zasshi. 2001 Jul;118(1):51-8. PMID 11496828
↑ Kaliner MA, Oppenheimer J, Farrar JR: Comprehensive review of olopatadine: the molecule and its clinical entities. Allergy Asthma Proc. 2010 Mar;31(2):112-9. PMID 20406593
↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs” . Nucleic Acids Res. 39 (Database issue): D1035-41. DOI :10.1093/nar/gkq1126 . PMC 3013709 . PMID 21059682 . edit
↑ David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets” . Nucleic Acids Res 36 (Database issue): D901-6. DOI :10.1093/nar/gkm958 . PMC 2238889 . PMID 18048412 . edit
↑ Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods” . J. Phys. Chem. A 102 : 3762-3772. DOI :10.1021/jp980230o .
↑ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices” . Chem Inf. Comput. Sci. 41 : 1488-1493. DOI :10.1021/ci000392t . PMID 11749573 . edit
↑ Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties” . J. Med. Chem. 43 : 3714-3717. DOI :10.1021/jm000942e . PMID 11020286 . edit
Literatura
Spoljašnje veze
Portal Medicina
Portal Hemija
Receptor
Agonisti :
2-Piridiletilamin •
Betahistin •
Histamin •
HTMT •
UR-AK49 Antagonisti :
1. generacija :
4-Metildifenhidramin •
Alimemazin •
Antazolin •
Azatadin •
Bamipin •
Benzatropin/Benztropin •
Bepotastin •
Bromazin •
Bromfeniramin •
Buklizin •
Kaptodiam •
Karbinoksamin •
Hlorciklizin •
Hloropiramin •
Hloroten •
Hlorfenamin •
Hlorfenoksamin •
Cinarizin •
Klemastin •
Klobenzepam •
Klocinizin •
Ciklizin •
Ciproheptadin •
Dacemazin •
Deptropin •
Deksbromfeniramin •
Dekshlorfeniramin •
Dimenhidrinat •
Dimetinden •
Difenhidramin •
Difenilpiralin •
Doksilamin •
Embramin • Etodroksizin •
Etibenzatropin/Etilbenztropin •
Etimemazin •
Flunarizin •
Histapirodin •
Homohlorciklizin •
Hidroksietilprometazin •
Hidroksizin •
Izoprometazin •
Izotipendil •
Meklozin •
Mepiramin/Pirilamin •
Mehitazin •
Metafurilen •
Metapirilen •
Metdilazin •
Moksastin •
Niaprazin •
Orfenadrin •
Oksatomid •
Oksomemazin •
Fenindamin •
Feniramin •
Feniltoloksamin •
Pimetiksen •
Piperoksan • Pipoksizin •
Prometazin •
Propiomazin •
Pirobutamin •
Talastin •
Tenalidin •
Tenildiamin •
Tiazinamijum •
Tonzilamin •
Tolpropamin •
Tripelenamin •
Triprolidin
2. generacija : Akrivastin • Alinastin • Astemizol • Azelastin • Bamirastin • Barmastin • Bepiastin • Bepotastin • Bilastin • Kabastinen • Karebastin • Ketirizin • Klemastin • Klemizol • Klobenztropin • Dorastin • Ebastin • Emedastin • Epinastin • Flezelastin • Ketotifen • Latrepirdin • Levokabastin • Linetastin • Loratadin • Mapinastin • Mebhidrolin • Mizolastin • Moksastin • Noberastin • Oktastin • Olopatadin • Perastin • Piklopastin • Rokastin • Rupatadin • Setastin • Talastin • Temelastin • Terfenadin • Zepastin
3. generacija : Desloratadin • Feksofenadin • Cetirizin • Levocetirizin
Negrupisani : Belarizin • Efletirizin • Elbanizin • Flotrenizin • Medrilamin • Napaktadin • Pibaksizin • Tagorizin • Trelnarizin • Trenizin • Vapitadin
Razni :
Triciklični antidepresanti (
amitriptilin , •
doksepin , •
trimipramin , itd) •
Tetraciklični antidepresanti (
mianserin , •
mirtazapin , itd) •
Tipični antipsihotici (
hlorpromazin , •
tioridazin , itd) •
Atipični antipsihotici (
klozapin , •
olanzapin , •
hetiapin , itd)
Transporter
Enzim
Drugi
The article is a derivative under the Creative Commons Attribution-ShareAlike License .
A link to the original article can be found here and attribution parties here
By using this site, you agree to the Terms of Use . Gpedia ® is a registered trademark of the Cyberajah Pty Ltd